VR17-04
VR17-04, the active metabolite of Enisamium, acts as a nucleoside analog inhibitor of viral RNA synthesis by blocking GTP and UTP incorporation, as demonstrated by computational studies. This mechanism supports its investigation as a potential broad-spectrum antiviral agent in both in vitro and animal model studies for COVID-19 and other RNA virus infections.
Product Specifications
CAS Number
2417925-64-3
Smiles
O=C (NCC=1C=CC=CC1) C2=CC=[N+] (C=C2O) C
Molecular Formula
C14H15N2O2
Molecular Weight
243.28
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6193330-01 0.1 mL
UNC119 (Protein Unc-119 Homolog A, Retinal Protein 4, RG4, hRG4, POC7, POC7A) (MaxLight 405)
Sign In for Pricing
View Details MBS6193330-02 5x 0.1 mL
UNC119 (Protein Unc-119 Homolog A, Retinal Protein 4, RG4, hRG4, POC7, POC7A) (MaxLight 405)
Sign In for Pricing
View Details MBS6463550-01 0.1 mL
APOA1, NT (Apolipoprotein A-I, Apo-AI, ApoA-I, Apolipoprotein A1, Apolipoprotein A-I(1-242)) (MaxLight 490)
Sign In for Pricing
View Details MBS6463550-02 5x 0.1 mL
APOA1, NT (Apolipoprotein A-I, Apo-AI, ApoA-I, Apolipoprotein A1, Apolipoprotein A-I(1-242)) (MaxLight 490)
Sign In for Pricing
View Details